[HTML][HTML] Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients

A Bobcakova, M Barnova, R Vysehradsky… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that spread around the
world during the past 2 years, has infected more than 260 million people worldwide and has …

[PDF][PDF] Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients

A Bobcakova, M Barnova, R Vysehradsky… - Front. Immunol. 13 …, 2022 - scienceopen.com
ORIGINAL RESEARCH published: 14 March 2022 doi: 10.3389/fimmu. 2022.861666
sensitivity or specificity to be considered a biomarker of fatal outcome. Understanding the …

Activated CD8 (+) CD38 (+) Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients

A Bobcakova, M Barnova, R Vysehradsky… - Frontiers In …, 2022 - lirias.kuleuven.be
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that spread around the
world during the past 2 years, has infected more than 260 million people worldwide and has …

Activated CD8+CD38+ cells are associated with worse clinical outcome in hospitalized COVID-19 patients.

A Bobcakova, M Barnova, R Vysehradsky, J Petriskova… - 2022 - cabidigitallibrary.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that spread around the
world during the past 2 years, has infected more than 260 million people worldwide and has …

[HTML][HTML] Activated CD8+ CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients

A Bobcakova, M Barnova, R Vysehradsky… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that spread around the
world during the past 2 years, has infected more than 260 million people worldwide and has …

Activated CD8+ CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients

A Bobcakova, M Barnova, R Vysehradsky… - Frontiers in …, 2022 - portal.research.lu.se
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that spread around the
world during the past 2 years, has infected more than 260 million people worldwide and has …

[PDF][PDF] Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients

A Bobcakova, M Barnova, R Vysehradsky… - Definition of the …, 2023 - researchgate.net
267 sensitivity or specificity to be considered a biomarker of fatal outcome. Understanding
the dynamic changes in immune profile of COVID-19 patients may help us to better …

Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients.

A Bobcakova, M Barnova, R Vysehradsky… - Frontiers in …, 2022 - europepmc.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that spread around the
world during the past 2 years, has infected more than 260 million people worldwide and has …

Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients

A Bobcakova, M Barnova, R Vysehradsky… - Frontiers in …, 2022 - lup.lub.lu.se
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that spread around the
world during the past 2 years, has infected more than 260 million people worldwide and has …

Activated CD8+ CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients

A Bobcakova, M Barnova… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that spread around the
world during the past 2 years, has infected more than 260 million people worldwide and has …